- Home
- RH vs PTGX Comparison
RH vs PTGX Comparison
Compare RH & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RH
- PTGX
- Stock Information
- Founded
- RH 1979
- PTGX 2006
- Country
- RH United States
- PTGX United States
- Employees
- RH N/A
- PTGX N/A
- Industry
- RH Other Specialty Stores
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- RH Consumer Discretionary
- PTGX Health Care
- Exchange
- RH Nasdaq
- PTGX Nasdaq
- Market Cap
- RH 3.1B
- PTGX 2.9B
- IPO Year
- RH 1998
- PTGX 2016
- Fundamental
- Price
- RH $181.08
- PTGX $47.47
- Analyst Decision
- RH Buy
- PTGX Strong Buy
- Analyst Count
- RH 16
- PTGX 8
- Target Price
- RH $278.25
- PTGX $66.50
- AVG Volume (30 Days)
- RH 1.1M
- PTGX 789.1K
- Earning Date
- RH 06-12-2025
- PTGX 05-06-2025
- Dividend Yield
- RH N/A
- PTGX N/A
- EPS Growth
- RH N/A
- PTGX N/A
- EPS
- RH 3.62
- PTGX 0.86
- Revenue
- RH $3,180,753,000.00
- PTGX $207,801,000.00
- Revenue This Year
- RH $13.94
- PTGX N/A
- Revenue Next Year
- RH $10.29
- PTGX $50.30
- P/E Ratio
- RH $50.03
- PTGX $55.04
- Revenue Growth
- RH 5.01
- PTGX N/A
- 52 Week Low
- RH $123.03
- PTGX $27.00
- 52 Week High
- RH $457.26
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- RH 41.76
- PTGX 58.60
- Support Level
- RH $180.33
- PTGX $45.43
- Resistance Level
- RH $193.04
- PTGX $46.80
- Average True Range (ATR)
- RH 8.46
- PTGX 1.54
- MACD
- RH -2.17
- PTGX 0.34
- Stochastic Oscillator
- RH 6.76
- PTGX 94.26
About RH RH
RH is a luxury furniture and lifestyle retailer operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 22 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade by expanding abroad, with its World of RH digital platform (highlighting offerings outside of home furnishings), and with offerings in architecture, media, and more.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.